← Eichor
Condition: Hepato Cellular Carcinoma Hcc Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepato Cellular Carcinoma Hcc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Impact of Anaesthesia and Sedation on Inflammation and NETosis in Hepatocellular Carcinoma Ablation
NA · 1 location(s) · Iuliu Hatieganu University of Medicine and Pharmacy · NCT07657897IIT2025-03-YANG-LIFT-HCC
Phase 2 · 1 location(s) · Ju Dong Yang · NCT07489976Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)
NA · 19 location(s) · University Hospital, Angers · NCT06990659PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
Phase 2 · 1 location(s) · West China Hospital · NCT06742424SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT07560566Fibroscan Evaluating Immunotherapy Response in Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Tanta University · NCT06960863A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma
Phase 2 · 1 location(s) · Fudan University · NCT07328009Hepatocellular Carcinoma Identification Using Delta-HLD
Phase N/A · 1 location(s) · Epiliquid Holding, Inc · NCT07148310Becotatug Vedotin (MRG003) in Previously Treated Advanced Hepatocellular Carcinoma
Phase 2 · 1 location(s) · Fudan University · NCT07536789PSYLIVER-PILOTE: Involvement of the Autonomic Nervous System in Hepatocellular Carcinoma (HCC)
NA · 1 location(s) · Hospices Civils de Lyon · NCT07393074HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients
Phase 2 · 3 location(s) · Fudan University · NCT06812039Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma
Phase 2/Phase 3 · 3 location(s) · University Hospital, Basel, Switzerland · NCT07302919PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma
Phase N/A · 1 location(s) · Tanta University · NCT06960954Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With Atezoli
Phase 2 · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT07276100Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
Phase 3 · 1 location(s) · Linhui Peng · NCT07267806Effect and Mechanism of ALPPS Operation on Liver Regeneration
Phase N/A · 1 location(s) · Haitao Zhao, MD · NCT07142213
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.